CLOS
ABBV icon

Compagnie Lombard Odier SCmA’s AbbVie ABBV Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-38,100
Closed -$13K – 597
2017
Q4 		$13K Buy
38,100
+3,100
+9% +$292K ﹤0.01% 567
2017
Q3 		$101K Buy
+35,000
New +$2.66M ﹤0.01% 436
2016
Q4 		– Sell
-7,100
Closed -$24K – 808
2016
Q3 		$24K Buy
+7,100
New +$460K ﹤0.01% 772

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ABBV Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $7.16M and leaving 276,074 shares worth $69.5M. The position accounts for 0.75% of the portfolio, ranked #29.

Compagnie Lombard Odier SCmA first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $203M in Q4 2015. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Compagnie Lombard Odier SCmA held 276,074 shares of AbbVie worth $69.5M as of Q2 2026.
  • Compagnie Lombard Odier SCmA sold 33,277 AbbVie shares in Q2 2026, an estimated $7.16M.
  • AbbVie made up 0.75% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #29 holding.
  • Compagnie Lombard Odier SCmA first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • Compagnie Lombard Odier SCmA's AbbVie position peaked at $203M in Q4 2015.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.